Deltamune & Vaxxinova Join Forces
The Netherlands, July 9, 2025 – Today we are pleased to announce the acquisition of Deltamune (Pty) Ltd (South Africa) from Phatisa.Deltamune is a leading Animal Health company in South Africa, specialized in African livestock solutions with in-house R&D and production capabilities for licensed and autogenous vaccines, covering Sub Saharan Africa.Phatisa is a respected African private […]
Read more →
Dechra announces sale of the Avishield® poultry vaccines portfolio to Vaxxinova
The Netherlands, June 17, 2025 — The Avishield portfolio currently consists of eight products manufactured, marketed and sold by Dechra into 29 countries. In addition, the Dechra poultry vaccine research and development (R&D) team of 24 people based in Zagreb, Croatia, and corresponding pipeline of potential future products, will also transfer to Vaxxinova upon completion, […]
Read more →
Historic Milestone Achieved: USDA Approves First-Ever Import of Live Vaccine into the United States.
Willmar, Minnesota — Vaxxinova US proudly announces a groundbreaking development for animal health and the poultry industry. The United States Department of Agriculture (USDA) has approved importation of a live Avian metapneumovirus vaccine, Vaxxon® SHS, into the U.S. market. This unprecedented approval marks a significant milestone in the fight against Avian metapneumovirus (aMPV). Vaxxon® SHS […]
Read more →
Vaxxinova®
Vaxxinova is committed to disease prevention in production animals. We aim to provide a complete set of vaccines and diagnostic services, supported by our global R&D network. Vaxxinova believes in ‘business without borders’ and long term partnerships with veterinarians and animal health professionals. We work together in disease prevention and livestock performance improvement programs. Our technical teams can advise you on our products and services.